TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Pact Pharma Stock

Pact Pharma Stock

pactpharma.comHealthcareFounded: 2017Funding to Date: $354.6MM

PACT Pharma clinical stage biotechnology company developing personalized adoptive T cell therapies for the eradication of solid tumors.

Buy or sell Pact Pharma stockLearn more about Pact Pharma IPO
Register for Details

For more details on financing and valuation for Pact Pharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Pact Pharma.

Register Today

Team

Management Team

Alex Franzusoff Ph.D
Chief Scientific Officer
Antoni Ribas Ph.D
Scientific Co-Founder & Board Member
Timothy Moore
Chief Technical Officer & President
Juan Jaen Ph.D
Co-Founder & Board Member
James Heath Ph.D
Scientific Co-Founder & Board Member
David Baltimore Ph.D
Scientific Co-Founder & Chairman of Scientific Advisory Board
Terry Rosen Ph.D
Co-Founder & Board Member
Blake Byers Ph.D
Interim President & Board Member

Board Members

Antoni Ribas Ph.D
Juan Jaen Ph.D
Terry Rosen Ph.D
David Baltimore Ph.D
James Heath Ph.D
Blake Byers Ph.D
KT Moortgat Ph.D
AbbVie Ventures

Other companies like Pact Pharma in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Colossal Biosciences
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Headspace
Sector
Healthcare
Last Round Est. Valuation
$298.33MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Allurion Technologies
Sector
Healthcare
 
 

News

FINSMES 01/13/2020
PACT Pharma Secures $75M in Series C Financing | FinSMEs
PACT Pharma, a SouthSan Francisco, Calif.-based advancing personalized NeoTCR-T cell therapies to eradicate solid tumors, closed a $75m Series C financing
PE Hub 10/02/2019
VC-backed PACT Pharma taps Moore as president and CTO | PE Hub
South San Francisco-based PACT Pharma, a provider of personalized cell therapy for solid tumors, has appointed Tim Moore as president and chief technical officer. Previously, Moore worked at Kite where he was executive vice president of technical operations. PACT Pharma's backers included GV, Canaan, Casdin Capital, Droia, Foresite Capital, Invus, Pontifax, Wu Capital, AbbVie Ventures and Taiho Ventures.

Trending Companies

Frequently Asked Questions